Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Ordinary Shares, par value Euro 0.01 per share
-
Shares outstanding
-
78.1M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
27.4M
-
Shares change
-
-721K
-
Total reported value, excl. options
-
$313M
-
Value change
-
-$8.25M
-
Number of buys
-
20
-
Number of sells
-
-13
-
Price
-
$11.52
Significant Holders of Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX) as of Q3 2024
42 filings reported holding ABVX - Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share as of Q3 2024.
Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.4M shares
of 78.1M outstanding shares and own 35.04% of the company stock.
Largest 10 shareholders include TCG Crossover Management, LLC (6.06M shares), Deep Track Capital, LP (3.58M shares), Cormorant Asset Management, LP (2.13M shares), GREAT POINT PARTNERS LLC (2.13M shares), Blackstone Inc. (1.52M shares), VR Adviser, LLC (1.35M shares), FRANKLIN RESOURCES INC (1.32M shares), COMMODORE CAPITAL LP (1.28M shares), Nantahala Capital Management, LLC (986K shares), and Samsara BioCapital, LLC (850K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.